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The effect of a diterpenoid isolated from Salvia cinnabarina, 3,4-seicosopimar-4(18),7,15-triene-3-oic acid
(SCB), on arterial blood pressure was evaluated in anaesthetized rats.
Male Wistar rats, anaesthetized with urethane (sol. 10% p/v; 10 mL/kg), underwent surgery for continuous
monitoring of arterial blood pressure. After preliminary experiments to evaluate the dose response (3, 10 and
30 mg/kg i.v.) of SCB, a dose of 3 mg/kg was chosen for all successive experiments. On different groups of rats
treated with the ganglion-blocking agent chlorisondamine (2.5 mg/kg i.p.) the effect of SCB (3 mg/kg i.v.) was
evaluated before and following an infusion of the nitric oxide synthase inhibitor L-NAME (0.3 mg/kg/min i.v.).
Intravenous administration of SCB at doses of 3, 10 and 30 mg/kg led to a fall in mean arterial blood pressure
(MABP) of 14.75 ± 1.44 mmHg, 36.60 ± 31.40 mmHg and 31.40 ± 6.28 mmHg, respectively (n = 4–5), that was
not modiﬁed by treatment of the rat with chlorisondamine nor with L-NAME. The results demonstrate a
hypotensive effect of SCB – due to a peripheral mechanism but independent of endothelial nitric oxide
release. Copyright © 2007 John Wiley & Sons, Ltd.
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INTRODUCTION
The genus Salvia is known for its wide spectrum of
pharmacological properties, such as antioxidant, anti-
bacterial, antifungal, antinociceptive, antiinﬂammatory
(Dobrynin et al., 1976; Hohmann et al., 1999; Baricevic
et al., 2001). Salvia cinnabarina is an American
species in the subgenus Calosphace, section Incarnate
(Epling, 1939) containing a high amount of oxygenated
monoterpenes (particularly linalool) and oxygenated
sesquiterpenes (Bisio et al., 1998). A new secoiso-
pimarane diterpenoid, namely 3,4-seicosopimar-
4(18),7,15-triene-3-oic acid (SCB), has been recently
isolated from the leaf exudates of aerial parts of S.
cinnabarina and tested for its biological properties. SCB
has been shown to have intestinal spasmolytic activity
in vitro, with an aspeciﬁc mechanism (Romussi et al.,
2001). In vivo, SCB inhibits mouse intestinal motility
with a mechanism involving L-type Ca2+ channels
(Capasso et al., 2004a). Furthermore, SCB inhibits rat
bladder contractility in vitro with the partial involve-
ment of nitric oxide (Capasso et al., 2004b). To further
characterize the pharmacological proﬁle of SCB, in the
present study investigated the effect of SCB on rat
arterial blood pressure.
MATERIAL AND METHODS
Animals. Male Wistar rats (200–250 g; Harlan Nossan),
housed under conditions of constant temperature (22–
24 °C) and humidity (50 ± 10%) under a 24 h light–
dark cycle with food and water freely available, were
used for the experiments. All animal experiments com-
plied with the Italian D.L. no. 116 of 27 January 1992
and Associated Guidelines in the European Communi-
ties Council Directive of 24 November 1986 (86/609/
ECC).
Drugs. Urethane, Nω-nitro L-arginine methyl ester (L-
NAME) and heparin were purchased from Sigma
(Milan, Italy). Chlorisondamine was purchased from
Tocris (UK). Extraction, isolation and structural char-
acterization of SCB were performed as described
previously (Romussi et al., 2001). HPLC analysis indi-
cated that SCB was 96% pure.
Measurement of arterial blood pressure. Male Wistar
rats were anaesthetized with urethane (sol 10% w/v
i.p.) and placed supine on an operating table. The right
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jugular vein was cannulated for drug administration,
the left carotid artery was cannulated with a cannula
containing heparinized saline (5 U/mL) and connected
to a pressure transducer (Basile, Comerio (VA), Italy)
for continuous monitoring of arterial blood pressure.
Acquisition data were performed by a computerized
system PowerLab (ADInstruments, v 3.4.3). After
surgery, the arterial blood pressure was allowed to
stabilize for about 30 min. The effect of three different
doses (3, 10 and 30 mg/kg i.v.) of SCB was tested in
different groups of animals. Each dose was admini-
stered on three consecutive times, for 20 min each,
in the same animals. Subsequently, a single admini-
stration of SCB (3 mg/kg i.v.) was chosen, after the
preliminary experiments in which each dose was
administered for three consecutive times in the same
animal.
Ganglion-blockade experiments. To eliminate any in-
ﬂuence of autonomic nervous system activation on
changes in mean arterial blood pressure (MABP) in-
duced by SCB, different groups of animals were pre-
treated with the irreversible ganglion-blocking agent
chlorisondamine at a dose of 2.5 mg/kg i.p., before
administering SCB (3 mg/kg i.v.) and changes in blood
pressure were evaluated.
Role of nitric oxide. The role of nitric oxide was
assessed by infusing L-NAME (0.3 mg/kg/min i.v.),
through a butterﬂy needle inserted into the caudal vein,
in ganglion blocked rats and changes in blood pressure
induced by SCB (3 mg/kg i.v.) were evaluated and com-
pared with values obtained before the infusion. The
dose of L-NAME chosen was able to restore blood pres-
sure in ganglion-blocked rats to the normal value.
Statistical analysis. Changes in MABP have been evalu-
ated as the difference from the basal value or as the
percentage change from the baseline, when groups
with different basal blood pressure were compared.
The results obtained are expressed mean ± SEM and
analysed by one-way analysis of variance (ANOVA)
followed by Bonferroni’s or Dunnett’s test, as appro-
priate. When requested, Student’s t-test was used.
A value of p < 0.05 was considered statistically
signiﬁcant.
RESULTS AND DISCUSSION
Intravenous administration of SCB (3–10 mg/kg i.v.) into
anaesthetized rats caused a transient dose-dependent
fall in MABP. The dose of 3 mg/kg i.v. caused a fall of
14.75 ± 1.44 mmHg; there was no tachyphylaxis after
repeated administrations of 20 min each into the same
animal and so this dose was chosen for all successive
experiments (Fig. 1). Hypotension induced by SCB
(3 mg/kg i.v.) was associated with a fall in heart rate
from 443 ± 24 to 264 ± 44 beats per minute (bpm) (p <
0.01; n = 9). To differentiate between a central and a
peripheral effect of SCB, experiments were performed
in groups of rats treated with the irreversible ganglion-
blocking agent chlorisondamine (2.5 mg/kg i.p.). After
treatment with chlorisondamine, the MABP value was
54.64 ± 1.59 mmHg (n = 11), signiﬁcantly different from
Figure 1. Decrease in MABP induced by SCB (3, 10 and 30 mg/
kg i.v.) in anaesthetized rats. Each dose of SCB was adminis-
tered in different groups of rats and repeated into the same
animals three consecutive times at 20 min intervals (n = 5).
the control value (p < 0.0001); however, the hypoten-
sive effect of SCB, evaluated as the percentage (%)
change in MABP, was not different from the control
animals (21.50 ± 6.76% vs 16.00 ± 2.38%), suggesting
that it does not involve the autonomic nervous system
activation deriving from a central effect of SCB. Inter-
estingly, in ganglion-blocked rats the hypotensive
effect of SCB was followed by a slight but signiﬁcant
hypertension (10.75 ± 2.14%; n = 4) that was not
evident before ganglion-blockade. Several studies descri-
bing the effect of L-NAME on changes in MABP
induced by drugs have been performed in normal
animals, in which the substantial increase in MABP
and vascular resistance above physiological values,
due to nitric oxide inhibition, might activate a reﬂex
response masking the real effect of drugs. For this
reason, to investigate on the possible role of nitric
oxide on changes in blood pressure induced by SCB,
experiments were performed on ganglion-blocked rats,
in which an infusion of L-NAME (0.3 mg/kg/min i.v.)
restored blood pressure to the normal value. Under
these conditions, no inhibition of SCB-induced hypo-
tension was observed, ruling out the involvement of
nitric oxide (Fig. 2A). This ﬁnding, together with the
observation that in ganglion-blocked rats SCB-induced
hypotension was not different from the value obtained
in normal, non-ganglion-blocked rats, suggests that the
vasodilator mechanism is due to a peripheral action
but independent from nitric oxide release. Interestingly,
following L-NAME infusion, hypertension that was
evident only after chlorisondamine treatment was abol-
ished (Fig. 2B). In conclusion, this is the ﬁrst work
demonstrating an in vivo hypotensive effect of SCB
due to a direct peripheral action but independent of
nitric oxide release. Our ﬁndings further contribute to
delineate the pharmacological proﬁle of this natural
compound.
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Figure 2. Change in MABP induced by SCB in ganglion-blocked rats and effect of L-NAME infusion. (a) Decrease in MABP
induced by SCB (3 mg/kg i.v.) before (white bar), after treatment with the ganglion-blocking agent chlorisondamine (2.5 mg/kg i.p.
solid bar) and in ganglion-blocked rats treated with an infusion of L-NAME (0.3 mg/kg/min i.v. hatched bar). (b) Increase in MABP
induced by SCB (3 mg/kg i.v.) before (white bar), after treatment with ganglion-blocking agent chlorisondamine (2.5 mg/kg i.p. solid
bar) and in ganglion-blocked rats treated with an infusion of L-NAME (0.3 mg/kg/min i.v. hatched bar) (n = 4–8, * p < 0.01 vs before
treatment with chlorisondamine and vs after L-NAME infusion).
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